Dror Ortho-Design, Inc. (OTC: DROR)

Dror Ortho-Design, Inc. is a medical device company focused on developing a proprietary AI based platform for correcting tooth alignment. The company was founded in 2005 as Dror Ortho-Design Ltd in Israel and after a share exchange in 2023 became Dror Ortho-Design, Inc a Delaware corporation. Its core product is the ZSmile system which uses a single smart aligner that delivers pulsating air to move teeth while the patient sleeps. The platform consists of a smartphone application an AI based cloud service and a Smart Aligner System that includes a base control unit and a mouthpiece with a micro balloon. ZSmile received FDA 510(k) clearance in February 2026 as a Class II medical device for the treatment of Class 1 and Class 2 malocclusion. Prior to ZSmile the company marketed the Aerodentis System which also uses pulsating air technology and obtained FDA clearance in April 2020. The Aerodentis System served as the foundation for the next generation ZSmile platform which adds AI driven image analysis and Internet of Things connectivity. Dror Ortho-Design, Inc. holds several U S patents covering the pulsating air mechanism the diagnostic workflow and the 3D printing of aligners.

As of the filing date Dror Ortho-Design, Inc. does not generate any revenue from its ZSmile platform. The company plans to earn income by selling the solution through a network of dental professionals who will provide the aligner and monitoring services to patients. Revenue will also be generated from ongoing monitoring services and periodic updates to treatment plans after initial correction is completed. In the longer term the company aims to sell directly to consumers when remote dental professional involvement can be arranged and regulatory approvals allow. The business model emphasizes recurring interactions with patients through the smartphone application and cloud based data analytics. Dror Ortho-Design, Inc. intends to invest approximately one million dollars over the next twelve months in software hardware development regulatory work and intellectual property protection.

Dror Ortho-Design, Inc. positions itself as a disruptive entrant in the clear aligner market. Its main competitors include Align Technology which markets Invisalign Dentsply Sirona which offers Byte 3M with its Clarity Aligners and Straumann Group. The company differentiates its ZSmile platform by using pulsating air technology that improves blood circulation and reduces discomfort compared to force based aligners. ZSmile requires only a single aligner per patient which lowers manufacturing complexity and enables the use of 3D printing for cost effective production. The AI based smartphone application and cloud service allow remote monitoring and reduce the need for frequent office visits. By targeting both orthodontists and general dentists the company expands its addressable practitioner base significantly because general dentists outnumber orthodontists roughly fifteen to one in the United States. Market research estimates the global clear aligner market could reach fifty six point eight billion dollars by 2033 and the company believes it can address a substantial portion of that opportunity. Intellectual property protection includes three issued U S patents and four pending applications covering core technology and related processes.

The company intends to serve dental professionals such as orthodontists and general dentists who will prescribe the ZSmile system to their patients. Patients seeking a discreet and less painful alternative to traditional braces or clear aligners constitute the end user group. Dror Ortho-Design, Inc. has not yet entered into formal agreements with specific dental clinics or practitioner groups but is building a network of providers interested in adopting the platform. Initial commercial efforts are focused on markets in Israel the United States the European Union the United Kingdom and Canada. The company also highlights the potential to reach a broader audience through direct to consumer channels once regulatory pathways permit remote professional oversight.